HSCS — Heart Test Laboratories Balance Sheet
0.000.00%
- $2.39m
- -$4.19m
- $0.01m
- 26
- 30
- 24
- 16
Annual balance sheet for Heart Test Laboratories, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.497 | 0.723 | 0.918 | 1.66 |
Net Total Accounts Receivable | ||||
Net Total Receivables | — | — | 0.002 | 0 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 1.54 | 1.64 | 1.93 | 2.7 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.418 | 0.289 | 0.159 | 0.591 |
Total Assets | 1.96 | 1.93 | 2.09 | 3.29 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.14 | 1.25 | 3.47 | 1.83 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 1.64 | 3.84 | 8.15 | 3.06 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 0.316 | -1.91 | -6.06 | 0.231 |
Total Liabilities & Shareholders' Equity | 1.96 | 1.93 | 2.09 | 3.29 |
Total Common Shares Outstanding |